Several studies found that the ApaI "aa" genotype was associated with higher PTH levels, increased bone turnover markers (such as intact osteocalcin), and a higher risk of secondary hyperparathyroidism in ESRD and hemodialysis patients [8,12,13]. Here, PTH is linked to secondary hyperparathyroidism.